Population Pharmacokinetic (PK) Evaluation of the Dipeptidyl Peptidase 1 (DPP1) Inhibitor Brensocatib in Healthy Participants and Patients With Bronchiectasis | Zendy

AI Assistant Blog Pricing

Population Pharmacokinetic (PK) Evaluation of the Dipeptidyl Peptidase 1 (DPP1) Inhibitor Brensocatib in Healthy Participants and Patients With Bronchiectasis

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.